(Press-News.org) Your genes are blueprints for proteins, and molecules called microRNA can help to determine how often these genetic blueprints are manufactured into proteins. Researchers often ask what microRNA regulates a gene related to disease. Or what gene is regulated by a microRNA found in sick patients? The answers to these questions could help doctors and researchers manipulate protein levels in the body that cause disease, especially cancer. A University of Colorado Cancer Center study recently published in the top-ranked journal Nucleic Acids Research (NAR) describes a database named multiMiR, the most comprehensive database collecting information about microRNAs and their targets.
"You can't imagine the tangled web of data that describes the cause and effect relationships of microRNAs and genes. This multiMiR database will let researchers search efficiently through these relationships for pairings relevant to the diseases they study," says Katerina Kechris, PhD, associate professor of Biostatistics and Informatics at the University of Colorado Denver, and one of the study's senior authors.
In addition to assisting researchers search for relationships between microRNAs and their genetic targets, the database includes drugs known to affect these microRNAs and also lists diseases associated with microRNAs.
"Right now, within this database, investigators can find clues to potential new treatments for various diseases including cancer," says Dan Theodorescu, MD, PhD, professor of Surgery and Pharmacology at the CU School of Medicine, director of the University of Colorado Cancer Center and one of the study's senior authors.
The project includes nearly 50 million records representing the combination of 14 previously existing microRNA data repositories. The multiMiR database also links to previous research results relevant to these microRNAs. multiMiR combines this functionality within the leading open-source statistical software, R, allowing for increased flexibility for analysis and accessibility by data analysts everywhere.
Basically, researchers can input names of microRNAs, genes, drugs, diseases or any combination thereof. Then the researcher can ask the database for validated or predicted genetic targets of microRNAs, or for validated/predicted microRNAs that regulate specific genes. Similar is true of diseases and drugs – informatics tools show which diseases are associated with microRNAs and which (if any) drugs have been linked to a specific miRNA queried.
Case studies described in the article show how microRNAs may affect voluntary alcohol consumption in mice, candidate genes within signaling pathways associated with chronic obstructive pulmonary disease, and the microRNA:gene interactions that influence bladder cancer.
"We need data and then we need clever ways to look at it otherwise we drown in the wealth of information," Theodorescu says. "This new tool will allow us to ask new questions of more data with greater precision and get better, more insightful results that will ultimately help develop new approaches for patient treatment."
INFORMATION:
Located on the Anschutz Medical Campus, the University of Colorado Cancer Center is Colorado's only National Cancer Institute-designated comprehensive cancer center, a distinction recognizing its outstanding contributions to research, clinical trials, prevention and cancer control. CU Cancer Center is a member of the prestigious National Comprehensive Cancer Network®, an alliance of the nation's leading cancer centers working to establish and deliver the gold standard in cancer clinical guidelines. Our primary clinical care partner, the University of Colorado Hospital, was recently ranked #15 for cancer care by U.S. News & World Report. CU Cancer Center is a consortium of more than 400 researchers and physicians at three state universities and six institutions, all working toward one goal: Translating science into life. For more information visit Coloradocancercenter.org and follow CU Cancer Center on Facebook and Twitter.
'Treatments waiting to be discovered' inside new database
2014-08-05
ELSE PRESS RELEASES FROM THIS DATE:
Monthly preventative treatment with a new drug combination reduces malaria in children
2014-08-05
Preventative treatment with a monthly dose of a newer antimalarial drug can reduce the risk of malarial infection among young children, according to a study published in this week's PLOS Medicine. The study, conducted by Victor Bigira and colleagues at San Francisco General Hospital and the Makerere University College of Health Sciences in Kampala, Uganda, finds that treating young children with dihydroartemisinin-piperaquine (DP) decreased their risk of contracting malaria.
Preventative treatment of malaria is a useful strategy to protect young children in Africa, but ...
Pregnant women are often given inappropriate treatment for malaria
2014-08-05
Not all pregnant women with symptoms of malaria seek care from their formal healthcare system and if they do seek care, they may be given inappropriate treatment because healthcare providers often fail to adhere to the standard (World Health Organization-WHO) diagnostic and treatment guidelines, according to a study by UK researchers published in this week's PLOS Medicine.
The authors (led by Jenny Hill from the Liverpool School of Tropical Medicine) reached these conclusions by reviewing all relevant studies that investigated the factors that affect pregnant women's ...
A campaign involving Muslim clerics has increased uptake of polio vaccination in Nigeria
2014-08-05
A coalition campaign involving imams, Islamic school teachers, traditional rulers, doctors, journalists, and polio survivors is gradually turning the tide against polio vaccine rejection in northern Nigeria, according to experts from Nigeria writing in this week's PLOS Medicine.
Sani-Gwarzo Nasir (from the Federal Ministry of Health in Nigeria) and colleagues describe how anti-polio propaganda, misconceptions, and violence against vaccinators present huge challenges to polio eradication in Nigeria but perhaps most profound is the rejection of vaccination by Muslim clerics.
However, ...
Just one simple question can identify narcissistic people
2014-08-05
COLUMBUS, Ohio – Scientists have developed and validated a new method to identify which people are narcissistic: just ask them.
In a series of 11 experiments involving more than 2,200 people of all ages, the researchers found they could reliably identify narcissistic people by asking them this exact question (including the note):
To what extent do you agree with this statement: "I am a narcissist." (Note: The word "narcissist" means egotistical, self-focused, and vain.)
Participants rated themselves on a scale of 1 (not very true of me) to 7 (very true of me).
(How ...
Salk scientists uncover new clues to repairing an injured spinal cord
2014-08-05
LA JOLLA—Frogs, dogs, whales, snails can all do it, but humans and primates can't. Regrow nerves after an injury, that is—while many animals have this ability, humans don't. But new research from the Salk Institute suggests that a small molecule may be able to convince damaged nerves to grow and effectively rewire circuits. Such a feat could eventually lead to therapies for the thousands of Americans with severe spinal cord injuries and paralysis.
"This research implies that we might be able to mimic neuronal repair processes that occur naturally in lower animals, which ...
Year-round preventive treatment reduces malaria risk in young children
2014-08-05
A year-round preventive drug treatment substantially reduces young children's risk of contracting malaria and poses no serious risk of adverse events, according to a study by researchers funded by the National Institutes of Health.
The findings demonstrate that prolonged treatment given from 6 to 24 months of age is safe and effective for young children, according to the study authors. Year-round preventive measures are badly needed in locations like Uganda, where the study took place, and where malaria rates remain high throughout the year.
Most previous studies using ...
How spiders spin silk
2014-08-05
Spider silk is an impressive material; lightweight and stretchy yet stronger than steel. But the challenge that spiders face to produce this substance is even more formidable. Silk proteins, called spidroins, must convert from a soluble form to solid fibers at ambient temperatures, with water as a solvent, and at high speed. How do spiders achieve this astounding feat? In new research publishing in the open access journal PLOS Biology on August 5, Anna Rising and Jan Johansson show how the silk formation process is regulated. The work was done at the Swedish University ...
In search for Alzheimer's drug, a major STEP forward
2014-08-05
Researchers at Yale School of Medicine have discovered a new drug compound that may help reverse the cognitive deficits of Alzheimer's disease. Their findings are publishing on August 5 in the open access journal PLOS Biology.
The compound, TC-2153, inhibits the negative effects of a protein called STriatal-Enriched tyrosine Phosphatase (STEP), which is key to regulating learning and memory. These cognitive functions are impaired in Alzheimer's.
"Decreasing STEP levels reversed the effects of Alzheimer's disease in mice," said lead author Paul Lombroso, M.D., professor ...
Pyruvate oxidation is critical determinant of pancreatic islet number and β-cell mass
2014-08-05
Researchers at the University at Buffalo, led by Dr. Mulchand Patel and also at Lawson Health Research Institute and Western Ontario, London, Canada, led by Dr. David Hill, collaboratively evaluated the role of the mitochondrial multienzyme pyruvate dehydrogenase complex in the regulation of pancreatic β-cell development and maturation in the immediate postnatal period in mice. This study, reported in the August 2014 issue of Experimental Biology and Medicine, demonstrated that the pyruvate dehydrogenase complex is not only required for insulin gene expression and ...
Butterflies change wing color in new Yale research
2014-08-05
Yale University scientists have chosen the most fleeting of mediums for their groundbreaking work on biomimicry: They've changed the color of butterfly wings.
In so doing, they produced the first structural color change in an animal by influencing evolution. The discovery may have implications for physicists and engineers trying to use evolutionary principles in the design of new materials and devices.
The research appears this week in the journal Proceedings of the National Academy of Sciences.
"What we did was to imagine a new target color for the wings of a butterfly, ...